CrossLink: a novel method for cross-condition classification of cancer subtypes

scientific article

CrossLink: a novel method for cross-condition classification of cancer subtypes is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1186/S12864-016-2903-Z
P932PMC publication ID5001207
P698PubMed publication ID27556419

P50authorIssam Al BozomQ62567160
P2093author name stringLotfi Chouchane
Yufei Huang
Erchin Serpedin
Yidong Chen
Yusheng Feng
Konduru S Sastry
Chifeng Ma
Mario Flore
Salah Gehani
P2860cites workThe MicroArray Quality Control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurementsQ24597089
Joint analysis of two microarray gene-expression data sets to select lung adenocarcinoma marker genesQ24792469
Cross-platform analysis of cancer microarray data improves gene expression based classification of phenotypesQ24811346
Angiogenic mRNA and microRNA gene expression signature predicts a novel subtype of serous ovarian cancerQ28732124
Exposing the cancer genome atlas as a SPARQL endpointQ28741373
The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroupsQ29614700
Supervised risk predictor of breast cancer based on intrinsic subtypesQ29617404
Fuzzy C-means method for clustering microarray dataQ30795735
Adjustment of systematic microarray data biasesQ30886734
Empirical Bayes accomodation of batch-effects in microarray data using identical replicate reference samples: application to RNA expression profiling of blood from Duchenne muscular dystrophy patientsQ33378251
WebArrayDB: cross-platform microarray data analysis and public data repositoryQ33482100
Heterogeneity for stem cell-related markers according to tumor subtype and histologic stage in breast cancer.Q33638070
Gene selection and classification for cancer microarray data based on machine learning and similarity measuresQ34173671
A comparison of PAM50 intrinsic subtyping with immunohistochemistry and clinical prognostic factors in tamoxifen-treated estrogen receptor-positive breast cancerQ34268261
Comparison of microarray platforms for measuring differential microRNA expression in paired normal/cancer colon tissues.Q34428112
PAM50 breast cancer subtyping by RT-qPCR and concordance with standard clinical molecular markers.Q34433549
Microarray analysis reveals that high mobility group A1 is involved in colorectal cancer metastasisQ34802972
Determination of minimum training sample size for microarray-based cancer outcome prediction-an empirical assessment.Q34827732
Comprehensive literature review and statistical considerations for microarray meta-analysisQ35955982
PAM50 assay and the three-gene model for identifying the major and clinically relevant molecular subtypes of breast cancerQ36147185
High-resolution aCGH and expression profiling identifies a novel genomic subtype of ER negative breast cancerQ36465618
PAM50 proliferation score as a predictor of weekly paclitaxel benefit in breast cancerQ36718459
PAM50 breast cancer intrinsic subtypes and effect of gemcitabine in advanced breast cancer patientsQ38393692
Synergistic antitumor activity of lapatinib and retinoids on a novel subtype of breast cancer with coamplification of ERBB2 and RARA.Q39447519
Estrogen-regulated genes predict survival in hormone receptor-positive breast cancersQ40310725
Estrogen receptor alpha and beta subtype expression and transactivation capacity are differentially affected by receptor-, hsp90- and immunophilin-ligands in human breast cancer cellsQ40428964
Merging two gene-expression studies via cross-platform normalizationQ48355571
P407language of work or nameEnglishQ1860
P304page(s)549
P577publication date2016-08-22
P1433published inBMC GenomicsQ15765854
P1476titleCrossLink: a novel method for cross-condition classification of cancer subtypes
P478volume17 Suppl 7

Reverse relations

Q31123316Intelligent biology and medicine in 2015: advancing interdisciplinary education, collaboration, and data sciencecites workP2860

Search more.